Search research articles
Contact Us
Filters
Showing results (261-270 of 541) with videos related to
Page
of 55
Sort By:
American Journal of Hypertension
|
November 1, 2024
Bladder Symptoms Provoked by Short, Rapid-Acting Loop Diuretics: A Frequent but Often Overlooked Problem
Christopher S Wilcox, Negiin Pourafshar, Karina Han, et al.
Internal and Emergency Medicine
|
November 17, 2021
Head-to-head comparison of diagnostic scores for acute heart failure in the emergency department: results from the PARADISE cohort
Tahar Chouihed, Adrien Bassand, Kevin Duarte, et al.
Drugs
|
October 11, 2021
Correction to: Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies
José M Valdivielso, Olga Balafa, Robert Ekart, et al.
Clinical Science (London, England : 1979)
|
April 1, 2017
A role for galectin-3 in the development of early molecular alterations in short-term aortic stenosis
Vanessa Arrieta, Ernesto Martinez-Martinez, Jaime Ibarrola, et al.
Drugs
|
July 27, 2021
Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies
José M Valdivielso, Olga Balafa, Robert Ekart, et al.
Journal of the American Heart Association
|
November 6, 2016
Role for Galectin-3 in Calcific Aortic Valve Stenosis
J Rafael Sádaba, Ernesto Martínez-Martínez, Vanessa Arrieta, et al.
Scientific Reports
|
December 21, 2016
Prognostic value of pulmonary congestion assessed by lung ultrasound imaging during heart failure hospitalisation: A two-centre cohort study
Stefano Coiro, Guillaume Porot, Patrick Rossignol, et al.
Clinical Kidney Journal
|
February 22, 2020
Arteriovenous fistula thrombosis is associated with increased all-cause and cardiovascular mortality in haemodialysis patients from the AURORA trial
Sophie Girerd, Nicolas Girerd, Luc Frimat, et al.
Diabetes, Obesity & Metabolism
|
June 12, 2019
Effect of the mineralocorticoid receptor antagonist eplerenone on liver fat and metabolism in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial (MIRAD trial)
Marie L Johansen, Morten Schou, Patrick Rossignol, et al.
Circulation. Heart Failure
|
May 2, 2020
Reduced Diuretic Dose in Patients Treated With Eplerenone: Data From the EPHESUS Trial
João Pedro Ferreira, Romain Eschalier, Kevin Duarte, et al.
Page
of 55
Search research articles
Search
Showing results (261-270 of 541) with videos related to
Sort By:
Page
of 55
American Journal of Hypertension
|
November 1, 2024
Bladder Symptoms Provoked by Short, Rapid-Acting Loop Diuretics: A Frequent but Often Overlooked Problem
Christopher S Wilcox, Negiin Pourafshar, Karina Han, et al.
Internal and Emergency Medicine
|
November 17, 2021
Head-to-head comparison of diagnostic scores for acute heart failure in the emergency department: results from the PARADISE cohort
Tahar Chouihed, Adrien Bassand, Kevin Duarte, et al.
Drugs
|
October 11, 2021
Correction to: Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies
José M Valdivielso, Olga Balafa, Robert Ekart, et al.
Clinical Science (London, England : 1979)
|
April 1, 2017
A role for galectin-3 in the development of early molecular alterations in short-term aortic stenosis
Vanessa Arrieta, Ernesto Martinez-Martinez, Jaime Ibarrola, et al.
Drugs
|
July 27, 2021
Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies
José M Valdivielso, Olga Balafa, Robert Ekart, et al.
Journal of the American Heart Association
|
November 6, 2016
Role for Galectin-3 in Calcific Aortic Valve Stenosis
J Rafael Sádaba, Ernesto Martínez-Martínez, Vanessa Arrieta, et al.
Scientific Reports
|
December 21, 2016
Prognostic value of pulmonary congestion assessed by lung ultrasound imaging during heart failure hospitalisation: A two-centre cohort study
Stefano Coiro, Guillaume Porot, Patrick Rossignol, et al.
Clinical Kidney Journal
|
February 22, 2020
Arteriovenous fistula thrombosis is associated with increased all-cause and cardiovascular mortality in haemodialysis patients from the AURORA trial
Sophie Girerd, Nicolas Girerd, Luc Frimat, et al.
Diabetes, Obesity & Metabolism
|
June 12, 2019
Effect of the mineralocorticoid receptor antagonist eplerenone on liver fat and metabolism in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial (MIRAD trial)
Marie L Johansen, Morten Schou, Patrick Rossignol, et al.
Circulation. Heart Failure
|
May 2, 2020
Reduced Diuretic Dose in Patients Treated With Eplerenone: Data From the EPHESUS Trial
João Pedro Ferreira, Romain Eschalier, Kevin Duarte, et al.
Page
of 55